The latest data from the AREST study, presented at the 2026 ASCO Annual Meeting, demonstrate that adjuvant radiation therapy following curative surgery for early-stage oral squamous cell carcinoma significantly improves disease-free survival. This underscores the importance of risk-adapted treatment planning for oral cavity tumors.
Autoren
- Dr. oec. Odile Schwarz-Herion
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
- adjuvant radiation therapy following curative surgery
- ASCO Annual Meeting 2026
- Checkpoint Inhibitors / PD-1/PD-L1
- CT/MRI and PET/CT
- Extranodal spread (ENE)
- FDG-PET
- Genomic-Adjusted Radiation Dose (GARD)
- Intensity-modulated radiation therapy (IMRT)
- multimodal therapy
- personalized treatment planning
- Pre-treatment risk stratification
- Radiotherapy / Radiation Therapy
- Squamous Cell Carcinoma of the Oropharynx (OPSCC)
- Surgical resection
- Transoral Robotic Surgery (TORS)
You May Also Like
- Ischemic stroke: Are smaller or larger brain arteries affected?
Recent study findings on intravenous lysis therapy with fibrinolytic agents
- Interview
“On par with the gold standards for trauma”
- Psychology: Emotional Freedom Techniques (EFT)
Emotional Healing Through Tapping
- Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?
Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs
- Psychedelic-assisted therapy
Current status of PAT
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Psoriasis and Obesity: Effects of Incretin-Based Therapies
Clinical trials shed light on the potential of semaglutide, liraglutide, and tirzepatide
- Non-small-cell lung cancer (NSCLC)